This function of SS18-SSX was further validated across three synovial sarcoma cell lines, where it was demonstrated that both CREB S133 phosphorylation and the expression of CREB downstream targets were contingent upon the presence of SS18-SSX. The gene discussed is SS18; the disease is synovial sarcoma.